文献速递腹部外周血管CTMR

肝表面结节定量在肝硬化患者临床显著门静脉高压诊断中的表现:钆贝葡胺增强MRI肝胆期序列与CT的比较

Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

回顾性纳入30例经组织学证实的代偿期肝硬化患者,比较CT门静脉期、T1加权门静脉期、T1加权肝胆期及T2加权MRI的肝表面结节定量评分对临床显著门静脉高压(CSPH)的诊断效能,各序列AUROC为0.801-0.908,组间无显著差异,MRI与CT诊断表现均较强且相似。

要点

  • CT门静脉期肝表面结节评分与肝静脉压力梯度相关性最高(r=0.63),AUROC达0.908±0.06。
  • MRI各序列(T1门静脉期、T1肝胆期、T2)AUROC为0.801-0.876,与CT pairwise比较无显著差异(p=0.12-0.88)。
  • CSPH患者各序列肝表面结节评分均高于无CSPH者,CT门静脉期正确分类率最高(86%)。

核心结论

  • 基于MRI的肝表面结节定量对CSPH的诊断效能强,与基于CT的肝表面结节定量相似。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2018年8月间30例经组织学证实的代偿期肝硬化患者,均在肝癌术前评估中于60天内完成肝静脉压力梯度测定、腹部CT及钆贝葡胺增强MRI。
  • 肝表面结节评分分别从CT门静脉期、轴位T2加权、T1加权门静脉期及肝胆期图像获取,以ROC曲线分析各图像集检测CSPH的准确性。
  • 采用组内相关系数(ICC)和变异系数(CV)评估观察者内、观察者间及方法间可重复性。

关键影像表现/征象

  • CSPH患者肝表面结节评分高于无CSPH者:CT门静脉期3.2±0.6 vs 2.4±0.5(p<0.001),T1加权门静脉期2.7±0.4 vs 2.2±0.4(p=0.002),T1加权肝胆期3.0±0.6 vs 2.3±0.3(p<0.001),T2加权3.0±0.6 vs 2.2±0.3(p=0.001)。

诊断标准与关键数值

  • CT门静脉期肝表面结节评分与HVPG相关(r=0.63,p=0.001),AUROC=0.908±0.06,正确分类率86%。
  • T1加权门静脉期与HVPG相关(r=0.43,p=0.028),AUROC=0.876±0.07,正确分类率82%。
  • T1加权肝胆期与HVPG相关(r=0.50,p=0.012),AUROC=0.823±0.08,正确分类率85%。
  • T2加权与HVPG相关(r=0.51,p=0.007),AUROC=0.801±0.09,正确分类率82%。
  • 各序列AUROC两两比较无显著差异(p=0.12-0.88)。

临床应用与阅片要点

  • 图像集间比较的可重复性优良(ICC=0.84-0.96,CV=8.3-14.2%)。
  • CT门静脉期、T1加权门静脉期、T1加权肝胆期及T2加权均可用于肝表面结节定量评估CSPH,诊断效能相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess and compare the performance of liver surface nodularity (LSN) quantification using Gd-BOPTA-enhanced MRI and contrast-enhanced CT for the diagnosis of clinically significant portal hypertension (CSPH) in patients with cirrhosis.

METHODS: This retrospective study included 30 patients with compensated histologically proven cirrhosis who underwent hepatic venous pressure gradient (HVPG), abdominal CT and Gd-BOPTA-MRI within a 60-day interval during pre-surgery workup for hepatocellular carcinoma (HCC) between January 2016 and August 2018. LSN score was derived from CT portal venous phase (PVP), axial T2- and T1-weighted PVP and hepatobiliary phase (HBP). Accuracy for the detection of CSPH was evaluated for each set of images by ROC curve analysis. Intra-observer, inter-observer and inter-method reproducibilities were assessed by the intraclass correlation coefficient (ICC) and coefficient of variation (CV).

RESULTS: Thirty patients were analysed (23 men [77%], mean age 60 ± 11 years old), including 15 (50%) with CSPH. All CT- and MRI-derived LSN quantifications were correlated to HVPG (CT-PVP: r = 0.63, p = 0.001, AUROC = 0.908 ± 0.06; T1-w-PVP: r = 0.43, p = 0.028, AUROC = 0.876 ± 0.07; T1-w-HBP: r = 0.50, p = 0.012, AUROC = 0.823 ± 0.08; T2-w: r = 0.51, p = 0.007, AUROC = 0.801 ± 0.09). There was no significant difference in AUROC pairwise comparisons (p = 0.12-0.88). Patients with CSPH had higher LSN than those without (CT-PVP: 3.2 ± 0.6 vs 2.4 ± 0.5, p < 0.001; T1-w-PVP: 2.7 ± 0.4 vs 2.2 ± 0.4, p = 0.002; T1-w-HBP: 3.0 ± 0.6 vs 2.3 ± 0.3, p < 0.001; T2-w: 3.0 ± 0.6 vs 2.2 ± 0.3, p = 0.001) and 86%, 82%, 85% and 82% of patients were correctly classified, respectively. Reproducibility of inter-image set comparisons was excellent (ICC = 0.84-0.96 and CV = 8.3-14.2%).

CONCLUSION: The diagnostic performance of MRI-based LSN for detecting CSPH is strong and similar to that of CT-based LSN.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. De Vos N, Sartoris R, Cauchy F, et al. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol (NY). 2020. PMID: 31797023. doi:10.1007/s00261-019-02355-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。